Secondary Logo

Journal Logo

September 1, 2019 - Volume 33 - Issue 11
pp: F13-F19,1683-1805

Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience

Spano, Jean-Philippe; Veyri, Marianne; Gobert, Aurélien; More

AIDS. 33(11):F13-F19, September 1, 2019.



HIV-mediated immune aging in young adults infected perinatally or during childhood

Fastenackels, Solène; Sauce, Delphine; Vigouroux, Corinne; More

AIDS. 33(11):1705-1710, September 1, 2019.


History of tuberculosis is associated with lower exhaled nitric oxide levels in HIV-infected children

Sovershaeva, Evgeniya; Kranzer, Katharina; Mchugh, Grace; More

AIDS. 33(11):1711-1718, September 1, 2019.

IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients

Wójtowicz, Agnieszka; Bibert, Stéphanie; Taffé, Patrick; More

AIDS. 33(11):1719-1727, September 1, 2019.


HIV diagnostic challenges in breast-fed infants of mothers on antiretroviral therapy

Strehlau, Renate; Paximadis, Maria; Patel, Faeezah; More

AIDS. 33(11):1751-1756, September 1, 2019.


Differences in sexually transmitted infection risk comparing preexposure prophylaxis users and propensity score matched historical controls in a clinic setting

Montaño, Michalina A.; Dombrowski, Julia C.; Dasgupta, Sayan; More

AIDS. 33(11):1773-1780, September 1, 2019.



Increasing levels of pretreatment HIV drug resistance and safety concerns for dolutegravir use in women of reproductive age

Inzaule, Seth Chekata; Jordan, Michael R.; Cournil, Amandine; More

AIDS. 33(11):1797-1799, September 1, 2019.